under-valued count trend
intern count trend
updat loan week
full comment requir non-u analyst conflict disclosur
pleas click link
initi coverag outperform rate
initi coverag outperform rate
preview differ quarter make
guide-down step-down
lower pt neg litig outcom
lower pt litig outcom
look eat preview outlook
takeaway itrm manag meet idweek
note road
deep dive frame colorado simplif analysi updat estim
week octob
price prior day market close estimate unless otherwis note
news nashvil
 of daili summari
specialti pharma
focus week
weekli perspect healthcar industri compani news valuat updat
continu digest learn last week
top investor question week payment processor servic
uptick deal flow optim wane amongst industri particip
find research
insight www rbcinsightresearch com global research destin web contact capit market sale
repres access global research site use ipad app research
initi coverag outperform rate
see strong opportun growth person care hospic segment
believ addu valuabl asset eye payor provid
price reflect revenu ebitda upsid potenti addu
consolid industri
valu usd unless otherwis note
small cap growth opportun healthcar servic becom rariti
believ addu healthcar opportun person care industri
histor overlook strateg servic provid stand-alon
busi model well investor busi model way
quit simpl high touch/ low tech healthcar heavi focu logist
approxim industri highli fragment recent
attract interest freestand scalabl consolid opportun
see recent legisl regulatori forc work govern
segment drive demand growth person care servic well
demand payor procur servic larger sophist
provid scale
addu growth prospect support age demograph
strong prefer age home demand rise believ larger
scale oper like addu emerg industri consolid present
favor back drop organ acquisit growth
initi coverag outperform rate price target
initi coverag outperform rate
believ neurovascular peripher vascular market
under-penetrated well posit take market share due superior
product line-up project revenu growth next three year
valu usd unless otherwis note
initi coverag outperform rate pt
larg
neurovascular peripher vascular market
under-penetrated particip estim neurovascular
peripher vascular believ neurovascular market
grow play fastest grow segment market
stroke grow meanwhil estim peripher market
grow market under-penetrated estim
elig patient current treat neuro peripher
respect
leader ischem stroke market acceler hold
ischem stroke market believ market pois acceler
aha updat recommend endovascular devic reason
first-lin treatment stroke expand treatment window given
releas sever major clinic trial guidelin updat alreadi
valu usd unless otherwis note
start see acceler stroke market evidenc pen
ischem stroke sale versu
pen peripher vascular busi post strong growth well ytd pen
peripher busi grown earli inning advanc
treatment paradigm peripher vascular diseas origin physician
thought tpa superior way treat peripher clot howev
forefront educ physician confid compani
deliv peripher revenu growth next three year
preview differ quarter make
posit develop around xifaxan ip cap believ
anoth quarter firm oper perform execut view investor
focu start shift toward long-term growth prospect busi
therefor focu outlook host bhc management
montreal toronto next week present key question team
expect revenu adj ebitda consensu
head print anticip revenu adj
ebitda compar consensu respect
thesi appear play question remain outstand
june note valuat updat plu thought mid-year consensu like
low highlight improv fundament balanc execut risk
new launch bhc delev event sinc time xifaxan ip
support former near-term headwind start abat focu
turn toward latter result long-term prospect prepar
host cfo paul herendeen head ir arthur shannon area focu
includ margin profil product mix shift time new product ramp
stabil free cash flow gener potenti equiti issuanc and/
busi develop see question though valuat keep us
sidelin given leverag note may attract given
signific valu could accru equiti holder debt repay
estim roll forward valuat basi target move
introduc ebitda estim consensu appli
target multipl ebitda estim combin dcf valuat
deriv price target prev
guide-down step-down
second guide-down month ceo chang mean stock much
near-term subject macro industri headlin perman ceo
name re-fram long-term plan uncertainti reign
howev dire scenario appear price new pt
valu usd unless otherwis note
valu usd unless otherwis note
guide-down ceo butterworth step dlph guid
announc ceo liam butterworth step role
presid chief execut offic pursu interest hari nair former
name interim ceo board commenc search
stock limbo credibl need rebuilt guide-down impli
fairli neg trend believ could persist
expect need come investor like lost faith prior outer-
year opportun commun acknowledg littl reason
investor look add posit perman ceo name
new outlook/plan commun could take number month
revis outlook pressur dlph guid organ growth
flat y/i vs prior guidanc believ issu highlight
earn china custom mix wltp persist broader weak
china wltp bigger longer impact thought highlight
vs prior ep estim go
prior pt
lower pt neg litig outcom
announc us district court eastern district virginia
richmond divis rule divestitur compani towanda facil
appropri remedi anti-trust litig steve believ
recent weak stock due grow belief/fear
would outcom still view develop neg
expect stock come pressur howev note
major financi impact estim divestitur towanda
would repres loss jeld global door skin capac
sale asset would like gener signific inflow cash wed
expect would use increment invest improv product
remain face facil potenti un-mothbal idl skin plant
growth invest acceler return cash sharehold think
potenti net financi impact manag still see signific opportun
improv profit next two year lower price target
repres ebitda ep
anticip outcom remain headwind jeld multipl
towanda facil vertic integr facil produc door skin
intern use third parti sale well hous jeld miratec
extira product line understand towanda gener mm
ebitda inclus intern consumpt door skin report
towanda gener mm extern sale total compani
estim extern ebitda attribut towanda could mm
remain mm relat intern consumpt divestitur
occur wed also expect cost door skin could rise given
loss vertic integr facil potenti higher price
new suppli agreement howev dont expect jeld ebitda would
reduc full mm especi sinc shift intern need
plant net think ballpark estim could mm lost
ebitda total compani importantli off-set would cash inflow
sale towanda estim could mm pre-
tax market cap assum multipl extern
valu usd unless otherwis note
final judgment year end
appeal unit state suprem court necessari appeal
process would extend addit month
divestitur would requir time appeal process
lower pt litig outcom
follow jeld announc us district court eastern district
virginia richmond divis rule divestitur compani towanda facil
appropri remedi anti-trust litig lower price target
like impact forecast long-term
uncertainti around industri dynam like remain overhang stock
trade multipl lower target ebitda multipl
valuat price repres ebitda
ep anticip greater uncertainti regard industri dynam
remain headwind door multipl
weekend announc us district court
district virginia richmond divis rule divestitur compani
towanda facil appropri remedi anti-trust litig steve
note rule becom final divestitur like
take place
towanda facil vertic integr facil produc door
skin well jeld miratec extira product line towanda jeld largest
skin manufactur facil volum well second largest facil
kind world mm skin produc estim
repres jeld total skin capac jeld face mill
order size locat dodson la klamath fall lativa craigsvil
look eat preview outlook
report result provid outlook thursday morn
bmo expect guidanc come ahead consensu power
share repurchas though concern price us market
follow compani commentari
need know report result provid
outlook thursday morn bmo expect guidanc come ahead
consensu power share repurchas though concern
price us market follow compani commentari
forecast ep in-lin street
forecast ahead street maintain
outperform rate share rais price target price
target reflect price-to-earnings multipl appli ep estim
valu usd unless otherwis note
valu usd unless otherwis note
takeaway itrm manag meet idweek
weekend iterum host event idweek san francisco
caught manag latest view sulopenem pivot
program data continu gener support develop
broader take overal market continu believ sulopenem
uniqu profil despit challeng anti-infect space see potenti
itrm share appreciationw maintain outperform specul risk rate
increment data present idweek highlight potenti
sulopenem uti market well compani approach design
oral sulopenem asset help get
pivot sulo program sure uuti cuti ciai respect
progress well sinc recent initi compani remain confid
timelin tactic plan
manag along infecti diseas stakehold investor
remain cogniz reput saddl anti-infect space
eye investor though follow convers confer
attende believ hint encourag gradual
improv sentiment
despit earli sign potenti optim id space overal
lack enamor larg pharma remain palpabl provid
import counterpoint still believ opportun focus
player like itrm keep eye ball capabl greater
appreci market
note road
work number oper challeng linger
expect turn appear occur seem
fairli clear glide path balanc year
view also reinforc fact manag slow
becom even select grow pool deal opportun
present reit
final hold attract valuabl home health care asset
estim current market valu much almost
share balanc stori appear leg long term
valu usd unless otherwis note
believ well posit maxim share rov subsea
product off-shore spend cycl shift gear compani aggress
yet dilig seek opportun leverag exist autom robot
technolog off-shore renew market
chang ep estim ep estim
street estim
report result oct focal point call
hot button topic may spur investor action
valu usd unless otherwis note
valu usd unless otherwis note
think post strong sep-qtr result help multipl factor
includ new product asp uplift benign memori cost servic tailwind
need know head sep-qtr earn think investor
sentiment larg neutral even slightli neg toward new iphon
abil maintain flat unit expect post sep-qtr
result slightli street expect driven revenu modest upsid
continu buy-back tailwind think new iphon launch
boost well unit note last year iphon delay
impli somewhat easier comp sep-qtr carrier promot
attract year could driver unit upsid addit think
other product segment could surpris posit given new watch
rise airpod attach rate overal see sep-qtr revenu mid/high
teen vs fx could slight headwind hedg program
larg off-set gm side addit asp dynam
start see impact lower memori price flow particularli
launch new iphon final servic momentum remain strong
outperform rate price target
deep dive frame colorado simplif analysi updat estim
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
receiv numer question potenti impact proposit
dcp cash flow believ manag potenti idr elimin
believ possibl earli provid analys report
updat estim revis commod price deck dcp prefer
unit issuanc maintain sector perform rate price target
proposit overhang colorado oil ga product proposit
would increas minimum distanc new oil ga drill
occupi buildings/vulner area feet current feet
high-occup build feet home
worst case scenario manag dcp view estim dj basin
repres dcp volum total ebitda
dcp report result market close host call
dial-in confirm code
valuat tabl power price frac spread data rel price perform
ex-dividend date
highlight weekli ag note includ new usmca trade agreement
wheat price increas russia expect export impact load work
suspens western corn belt get lot rain ag economi baromet updat
brazil farm lobbi back far-right candid taiwan purchas anoth
us soybean us expir gdt index fell two-year low iraq
reduc crop plant area morocco cancel soft wheat custom
under-valued count trend
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
clb fall line indic street number high read
reduc estim updat guidanc
cut frac sand volum manag reduc volum growth
highlight northern white price pressur read reduc estim
global oilfield servic intern count trend
septemb rig count ran rig forecast primari differenti
land total intern activ averag vs forecast
put take
aggreg largest increas activ month driven mexico
ad rig interestingli countri ad rig sinc novemb
low largest decreas came egypt drop rig septemb
largest increas quarter africa specif libya rig
year-to-d rig activ africa increas rig
quarter quarter rig count increas far east specif
china year-to-d averag rig activ countri remain steadi
rig run
updat loan week
weekli industri loan non-season adjust loan
week-over-week w/w basi end septemb
year-over-year y/i basi follow trend
commerci industri w/w y/i
consum w/w y/i
commerci estat w/w y/i
residenti estat w/w y/i
equiti w/w y/i
w/w y/i
week octob
coverag univers three easi pictur use pictur comment
key driver insur reinsur life insur market
insur price begun improv concern whether
increas seen far enough off-set rise loss cost trend
comment outlook reinsur price neg feedback loop
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
could primari insur price also look recent annuiti
flow weak comment posit neg within
life insur space also recap stock price perform sinc
earn season see share much fairli valu fewer
visibl catalyst near-term life share still see attract posit
ralli previou investor concern resolv
stand book yield rate treasuri yield push
mani life compani could soon posit start see
book yield start rise mani suggest break-even point
look book yield theyv
chang last year also recap report new money yield
annuiti life sale limra recent publish industri sale
figur review sale trend across key product categori industry-wid
fix annuiti sale increas significantli quarter variabl annuiti
sale saw modest increas well tradit life insur product sale pick
amz close posit second consecut quarter
first time sinc amz peak week take look
amz perform rel index midstream name
across coverag univers perform
note amz continu under-perform broader
due continu weak fund flow outperform xop oih
bp respect
note name expos activ colorado
bp lower amz quarter proposit continu
increasingli weigh stock exposur colorado ahead novemb
highlight weekli mine note includ rio invest two
iron ore project au drc expect copper prod y/i vale expect
approv salobo copper expans au expect china steel prod peak
peru expect mine invest reach next year
glencor price thermal coal contract y/i rio confirm agreement
sell grasberg stake poland increas coal output peabodi expect
product north goonyella coal mine due fire copper mountain mine
feasibl studi expect cu prod per year ivanho mine made third
high-grad copper discoveri exxaro interest local coal asset eu
extend duti russian steel iron pipe five year
news nashvil
weekli perspect healthcar industri compani news valuat
sector price perform week end octob healthcar servic
stock under-perform broader market health servic
select index spsihp declin versu declin
 diagnost imag strongest-perform sub-
gain prior week manag lost versu gain prior
week weakest-perform sub-sector last week ambulatori surgeri
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
week attend cerner health confer
get anoth chanc sit ceo brent shafer get better
understand strateg vision compani also
earn call watch develop acquisit aetna
hpc wal-mart de mexico report septemb comp sale mexico
central america consolid basi septemb total sale
growth gillett introduc new on-line direct-to-consum
servic gillett demand canada alreadi begun receiv order
harri investig categori could bring disrupt
provid conveni consum
beverag sold bottl unit canada canada
bottl cccbl announc new cinnamon flavour
zero sugar uk holiday season pepsico india made profit
gap seven year back cost-effici measur higher capac
util focu high-margin product constel announc
octob mallika monteiro promot senior vice presid
chief growth offic report newland presid chief oper
offic suntori re-launch sauza brand mexico order
recov leadership posit year ago well achiev great
close year
tobacco lobbi feder govern
australia overturn australia ban vape philip morri korea said file
lawsuit south korean govern demand disclosur
